BRIEF-NRX Pharma Files Initial Section Of U.S. New Drug Application To The FDA For NRX-100
ReutersDec 30, 2024 1:14 PM
Dec 30 (Reuters) - NRX Pharmaceuticals Inc NRXP.O:
NRX PHARMACEUTICALS, INC. (NASDAQ:NRXP) FILES INITIAL SECTION OF U.S. NEW DRUG APPLICATION TO THE FDA FOR NRX-100 (IV KETAMINE) FOR THE TREATMENT OF SUICIDAL DEPRESSION
NRX PHARMACEUTICALS INC - COMPLETION OF NDA FILING EXPECTED IN Q1 2025
Source text: ID:nPn5zkNhra
Further company coverage: NRXP.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
MGM Resorts International (MGM): Huge Potential in Online Gaming
TradingKey - MGM seems undervalued, as the market does not appreciate the potential of the company’s online betting business, which has a very high growth at 25% and real possibility to have much higher profitability than the traditional on-ground casino business.TradingKey
7 hours ago
U.S. Stock Strategy: The Rapid Development of AI Signals a Promising Future
TradingKey - Since Trump announced a 90-day suspension of the "reciprocal tariffs" imposed on certain countries on 9 April this year, all three major U.S. stock indices have recorded significant gains. Looking ahead, against the backdrop of easing global trade frictions.TradingKey
8 hours ago
Size Matters? Royal Caribbean Cruises Don’t Think So
TradingKey - Royal Caribbean Group (RCL), as the world’s second-largest cruise operator, demonstrates industry-leading recovery and competitive strength in the post-pandemic era through robust revenue growth (18.6% increase in 2024, with net income surging 70.6%), exceptional operational efficiencyTradingKey
12 hours ago
China July Inflation Commentary: CPI Exceeds Expectations
TradingKey - On 9 August 2025, China's National Bureau of Statistics released inflation data for July. The Consumer Price Index (CPI) rose by 0.4% month-on-month, reversing the previous month's 0.1% decline, while remaining unchanged year-on-year. Core CPI increased by 0.8% year-on-year.TradingKey
18 hours ago
U.S. CPI Preview: Bullish Outlook for U.S. Stocks Continues
TradingKey - On 12 August 2025, the U.S. will release its July CPI data. Market consensus forecasts a year-over-year headline CPI increase of 2.8% and a core CPI rise of 3%, both up 0.1 percentage points from June. We align with these widely held market expectations. Breaking it down by category...TradingKey
18 hours ago
